Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 41, Issue 7, Pages 1100-1108Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/03639045.2014.931967
Keywords
Amorphous; apparent permeability coefficient; azithromycin; dissolution; solubility; vapor sorption
Categories
Funding
- National Research Foundation (NRF)
- Centre of Excellence for Pharmaceutical Sciences of the North-West University, Potchefstroom, South Africa
Ask authors/readers for more resources
Azithromycin (AZM) is a poorly soluble macrolide antibacterial agent. Its low solubility is considered as the major contributing factor to its relatively low oral bioavailability. The aim of this study was to improve the solubility of this active pharmaceutical ingredient (API) by preparing an amorphous form by quench cooling of the melt and to study the influence of the improved solubility on membrane permeability. The amorphous azithromycin (AZM-A) exhibited a significant increase in water solubility when compared to the crystalline azithromycin dihydrate (AZM-DH). The influence that the improved solubility could have on membrane permeability was also studied. The apparent permeability coefficient (Papp) values of AZM-A were statistically significantly higher (p < 0.05) than crystalline AZM-DH at pH values of 6.8 and 7.2. The results therefore indicated that the improved solubility of AZM in the amorphous form also produced improved permeability across excised intestinal tissue at physiological pH values found in the small intestine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available